FinscoFinsco

Inspire Medical Systems (US.INSP)

Capital Allocation Audit · Period: 2015 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.INSP · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion24.3%↓
ROE-1.4%↓
Cash Conversion-→
D/E Ratio0.04↑
Gross Margin86.5%→
US.INSP (Inspire Medical Systems) | YoY: 2026 Q1 vs 2025 Q1


Metric           Value  YoY
---------------------------
FCF Conversion   24.3%    ↓
ROE              -1.4%    ↓
Cash Conversion      -    →
D/E Ratio         0.04    ↑
Gross Margin     86.5%    →
Key Metrics
US.INSP (Inspire Medical Systems) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
---------------------------
FCF Conversion 24.3% ↓
ROE -1.4% ↓
Cash Conversion - →
D/E Ratio 0.04 ↑
Gross Margin 86.5% →

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies